Relizorb Use Supports Weight, Height Gains in Tube-fed Patients, Study Finds
Relizorb, Alcresta Therapeutics‘ pancreatic enzyme treatment, led to significant weight and height improvements among cystic fibrosis (CF) patients with pancreatic insufficiency who require tube feeding, according to the results of a 12-month observational study. The analysis of that study, “Evaluation of the Effectiveness…